Now showing items 1-1 of 1

  • Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial 

    Chataway, J; De Angelis, F; Connick, P; Parker, RA; Plantone, D; Doshi, A; John, N; Stutters, J; MacManus, D; Prados Carrasco, F; Barkhof, F; Ourselin, S; Braisher, M; Ross, M; Cranswick, G; Pavitt, SH; Giovannoni, G; Gandini Wheeler-Kingshott, CA; Hawkins, C; Sharrack, B; Bastow, R; Weir, CJ; Stallard, N; Chandran, S; Chataway, J; Gandini Wheeler-Kingshott, CAM; De Angelis, F; Plantone, D; Doshi, A; John, N; Williams, T; Braisher, M; Beyene, T; Bassan, V; Zapata, A; Chandran, S; Connick, P; Lyle, D; Cameron, J; Mollison, D; Colville, S; Dhillon, B; Weir, CJ; Parker, RA; Ross, M; Cranswick, G; Giovannoni, G; Gnanapavan, S; Nicholas, R; Rashid, W; Aram, J; Ford, H; Overell, J; Young, C; Arndt, H; Duddy, M; Guadagno, J; Evangelou, N; Craner, M; Palace, J; Hobart, J; Sharrack, B; Paling, D; Hawkins, C; Kalra, S; McLean, B; Stallard, N; Bastow, R (Elsevier BV, 2020-03)

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV